글리코바이올로지 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Glycobiology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,227,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,555,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,291,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 글리코바이올로지(Glycobiology) 시장에 대한 상세한 조사 보고서를 발표했습니다. 이 보고서는 시장 촉진요인, 동향, 기회 및 과제와 같은 주요 시장 역학을 자세히 분석하여 시장 구조에 대한 깊은 인사이트를 제공합니다.

주요 인사이트

• 글리코바이올로지 시장 규모(2024E) : 17억 달러
• 예상 시장 가치(2033F) : 54억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 13.7%

글리코바이올로지 시장 - 보고서 범위:

글리코바이올로지 시장은 생물학적 시스템에서 당쇄(글리칸)의 구조, 기능, 생물학에 대한 연구 및 분석을 포함합니다. 글리코바이올로지는 세포 신호전달, 면역반응, 질병 진행 등 다양한 생물학적 과정을 이해하는 데 중요한 역할을 합니다. 시장은 신약개발, 진단학, 종양학, 면역학 등 용도별로 세분화되어 있습니다. 성장의 원동력은 글리코믹스 연구 활동의 증가, 개인 맞춤형 의료에 대한 수요 증가, 글리칸 분석 기술의 발전입니다.

시장 성장 촉진요인:

세계 글리코바이올로지 시장을 이끄는 몇 가지 주요 요인은 다음과 같습니다. 바이오의약품 연구개발에 대한 관심 증가와 신약 개발 및 질병 진단에 대한 글리코바이올로지 적용 증가는 주요 성장 촉진요인입니다. 질량 분석 및 크로마토그래피 기술의 발전은 보다 정확하고 효율적인 당쇄 분석을 가능하게함으로써 시장 확대에 박차를 가하고 있습니다. 또한, 암 및 당뇨병과 같은 만성 질환의 유병률 증가는 표적 치료법 개발에서 글리코바이올로지의 중요성을 강조하며 시장 성장을 촉진하고 있습니다. 질병을 조기에 발견하기 위한 글리코바이오마커의 사용 확대와 치료용 글리코엔지니어링에 대한 관심이 높아지는 것도 시장 성장에 큰 기여를 하고 있습니다.

시장 억제요인:

유망한 성장 전망에도 불구하고, 글리코바이올로지 시장은 당쇄 분석의 복잡성과 고급 글리코바이올로지 연구 도구와 관련된 높은 비용과 관련된 도전에 직면해 있습니다. 표준화된 프로토콜의 부재와 당쇄 분석에 대한 전문 지식이 필요하기 때문에 소규모 연구 기관은 글리코바이올로지 기술의 채택을 제한할 수 있으며, 이는 시장 성장을 저해할 수 있습니다. 또한, 글리코바이올로지 기술을 임상 진료에 통합하는 것은 아직 초기 단계에 있으며, 연구 결과를 치료 적용에 적용하는 데 어려움이 있습니다. 이러한 문제를 해결하기 위해서는 교육 및 훈련에 대한 지속적인 투자와 더 많은 연구자와 임상의가 글리코바이올로지를 보다 광범위하게 이용할 수 있도록 비용 효율적인 도구와 기술을 개발해야 합니다.

시장 기회:

이 시장은 당쇄 기반 진단 방법의 채택 증가와 혁신적인 치료 솔루션에 대한 수요 증가로 인해 큰 기회를 창출하고 있습니다. 더 높은 민감도와 특이성을 갖춘 차세대 당쇄 분석 도구의 개발은 정밀의료에 대한 수요 증가에 대응하고 있습니다. 신흥국에서의 연구 활동 확대, 학술 기관과 바이오 제약 기업 간의 협력 증가는 시장 성장의 새로운 채널을 제공하고 질병 치료 및 예방에 대한 글리코바이오로직스의 새로운 응용을 모색할 수 있는 기회를 제공합니다. 전략적 파트너십, 첨단 기술에 대한 투자, 그리고 글리코바이오로직스 기반 맞춤 의료의 도입은 새로운 기회를 활용하고 시장 리더십을 유지하는 데 있어 필수적입니다.

본 보고서에서 다루는 주요 질문들

• 세계 글리코바이올로지 시장의 성장을 촉진하는 주요 요인은 무엇인가?
• 어떤 종류의 글리코바이올로지 종류와 용도가 다양한 분야에서 채택을 주도하고 있는가?
• 기술 발전은 글리코바이올로지 시장의 경쟁 구도에 어떤 영향을 미치고 있는가?
• 글리코바이올로지 시장의 주요 플레이어는 누구이며, 경쟁력을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 글리코바이올로지 시장의 새로운 트렌드와 향후 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 핵심성공요인

• 제품 채용/사용 상황 분석
• 제품 USP/특징
• 최근의 제품 승인과 발매
• PESTLE 분석
• Porters 분석
• 규제 시나리오
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 역학

제6장 COVID-19 위기 - 영향 평가

• COVID-19와 영향 분석
  • 제품별
  • 효소별
  • 용도별
  • 최종사용자별
  • 지역별
• 2024년 시장 시나리오

제7장 세계 시장 수요(금액 및 규모) 분석

• 시장(금액) 분석, 2019-2023년
• 시장(금액) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제8장 제품별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 기기
  • 효소
  • 소모품
  • 키트와 시약
• 제품별 시장 매력 분석

제9장 효소별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 갈락토시다아제
    • 푸코시다아제
    • 키티나아제
    • 아세틸갈락토사미니다아제
    • 헤파리나아제
    • PNGase F
    • 기타
  • GlcNAc 트랜스페라제
    • 아세틸글루코사미닐트랜스페라제
    • 엑소스토신
    • 기타
  • 푸코실트랜스페라제
  • GalNAc 트랜스페라제
  • 갈락토실트랜스페라제
  • 글루쿠로노실트랜스페라제
  • 글루코실트랜스페라제
  • 펜토실트랜스페라제
  • 탄수화물 키나아제
  • 뉴라미니다제
  • 시알릴트랜스페라제
  • 기타
• 효소별 시장 매력 분석

제10장 용도별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 의약품 발견과 개발
  • 진단 애플리케이션
    • 종양학
    • 면역학
    • 기타
  • 산업 용도
  • 치료 용도
    • 종양학
    • 면역학
    • 기타
  • 기타
• 용도별 시장 매력 분석

제11장 최종사용자별 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 바이오의약품 기업
  • 실험실
  • 병원
  • 진단 센터
  • 수탁연구기관
  • 바이오테크놀러지 산업
  • 학술기관
  • 기타
• 최종사용자별 시장 매력 분석

제12장 지역별 : 세계 시장 분석

• 소개
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장 매력 분석

제13장 북미 시장 분석

제14장 라틴아메리카 시장 분석

제15장 유럽 시장 분석

제16장 남아시아 시장 분석

제17장 동아시아 시장 분석

제18장 오세아니아 시장 분석

제19장 중동 및 아프리카 시장 분석

제20장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 브랜딩과 프로모션 전략
• 주요 개발 분석
• 경쟁 상세
  • Glycodiag
  • Tracxn Technologies Limited
  • Agilent Tecnologies, Inc.
  • Takara Bio Inc.
  • Bio-Techne
  • Bruker Corporation
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • New England Biolabs.
  • Waters.co.
  • Merck KGaA
  • Palleon Pharmaceuticals
  • Asparia Glycomics
  • RayBiotech Life,Inc.
  • Z Biotech,LLC.
  • Chemily Glycoscience
  • Lectenz Bio
  • 2BScientific

제22장 사용되는 가정과 두문자어

제23장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently published an in-depth report on the global Glycobiology Market. This report provides a detailed analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, offering deep insights into the market structure.

Key Insights:

• Glycobiology Market Size (2024E): USD 1.7 Bn
• Projected Market Value (2033F): USD 5.4 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 13.7%

Glycobiology Market - Report Scope:

The Glycobiology Market involves the study and analysis of the structure, function, and biology of carbohydrates (glycans) in biological systems. Glycobiology plays a crucial role in understanding various biological processes, including cell signaling, immune response, and disease progression. The market is segmented by application, including drug discovery and development, diagnostics, oncology, and immunology, among others. Growth is driven by increasing research activities in glycomics, the rising demand for personalized medicine, and advancements in glycan analysis technologies.

Market Growth Drivers:

Several key factors are driving the global Glycobiology Market. The rising focus on research and development in biopharmaceuticals and the increasing application of glycobiology in drug discovery and disease diagnosis are major growth drivers. The ongoing advancements in mass spectrometry and chromatography technologies further fuel market expansion by enabling more accurate and efficient glycan analysis. Additionally, the growing prevalence of chronic diseases, such as cancer and diabetes, underscores the importance of glycobiology in developing targeted therapies, thereby boosting market growth. The expanding use of glycan biomarkers in early disease detection and the growing interest in glyco-engineering for therapeutic applications also contribute significantly to the market's growth.

Market Restraints:

Despite the promising growth prospects, the Glycobiology Market faces challenges related to the complexity of glycan analysis and the high costs associated with advanced glycobiology research tools. The market growth may be hindered by the lack of standardized protocols and the need for specialized expertise in glycan analysis, which can limit the adoption of glycobiology technologies in smaller research institutions. Additionally, the integration of glycobiology into clinical practice is still in its nascent stages, posing challenges in translating research findings into therapeutic applications. Addressing these issues requires ongoing investment in training and education, as well as the development of cost-effective tools and techniques to make glycobiology more accessible to a broader range of researchers and clinicians.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of glycan-based diagnostics and the rising demand for innovative therapeutic solutions. The development of next-generation glycan analysis tools with higher sensitivity and specificity caters to the growing need for precision medicine. The expansion of research activities in emerging economies and the increasing collaboration between academic institutions and biopharmaceutical companies provide new channels for market growth, allowing for the exploration of novel applications of glycobiology in disease treatment and prevention. Strategic partnerships, investments in cutting-edge technologies, and the introduction of glycan-based personalized medicine are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Glycobiology Market globally?
• Which types and applications of glycobiology are leading the adoption in various sectors?
• How are technological advancements influencing the competitive landscape of the Glycobiology Market?
• Who are the key players in the Glycobiology Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Glycobiology Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Glycobiology Market, including Thermo Fisher Scientific, Agilent Technologies, and Merck KGaA, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest heavily in R&D to develop advanced glycobiology tools and explore new applications in drug development and diagnostics. Collaborations with academic institutions, research organizations, and biotechnology firms facilitate market access and promote the adoption of new technologies. Emphasis on customer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Glycobiology Market landscape.

Key Companies Profiled:

• Glycodiag
• Tracxn Technologies Limited
• Agilent Tecnologies, Inc.
• Takara Bio Inc.
• Bio-Techne
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Shimadzu Corporation
• New England Biolabs.
• Waters.co.
• Merck KGaA
• Palleon Pharmaceuticals
• Asparia Glycomics
• RayBiotech Life,Inc.
• Z Biotech,LLC.
• Chemily Glycoscience
• Lectenz Bio
• 2BScientific

Glycobiology Market Industry Segmentation

Product:

• Instruments
• Enzymes
• Consumables
• Kits and Reagents

By Enzyme:

• Galactosidases
• GlcNAc Transferases
• Fucosyltransferases
• GalNAc Transferases
• Galactosyl Transferases
• Glucuronosyltransferases
• Glucosyltransferases
• Pentosyltransferases
• Carbohydrate Kinases
• Neuraminidases
• Sialyltransferases
• Others

Application:

• Drug Discovery and Development
• Diagnostic Applications
• Industrial Applications
• Therapeutic Applications
• Others

End User:

• Biopharmaceutical Companies
• Research Laboratories
• Hospitals
• Diagnostic Centers
• Contract Research Organizations
• Biotechnology Industries
• Academic Institutes
• Others

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Recent Product Approval and Launches
• 4.4. PESTLE Analysis
• 4.5. Porter's Analysis
• 4.6. Regulatory Scenario
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Enzymes Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising Geriatric Population
  • 5.2.2. Funding Through Government Bodies
  • 5.2.3. Technological Advancements
  • 5.2.4. Mergers and Acquisitions
  • 5.2.5. Cost of Glycobiology Products
  • 5.2.6. Increasing Incidence of Congenital Disorders
  • 5.2.7. Growing Investments in Precision Medicine Development
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Enzyme
  • 6.1.3. By Application
  • 6.1.4. By End User
  • 6.1.5. By Region
• 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
  • 8.3.1. Instruments
  • 8.3.2. Enzymes
  • 8.3.3. Consumables
  • 8.3.4. Kits and Reagents
• 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Enzyme

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis By Enzyme, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Enzyme, 2024-2033
  • 9.3.1. Galactosidases
    • 9.3.1.1. Fucosidases
    • 9.3.1.2. Chitinases
    • 9.3.1.3. Acetylgalactosaminidase
    • 9.3.1.4. Heparinase
    • 9.3.1.5. PNGase F
    • 9.3.1.6. Others
  • 9.3.2. GlcNAc Transferases
    • 9.3.2.1. Acetylglucosaminyltransferase
    • 9.3.2.2. Exostosin
    • 9.3.2.3. Others
  • 9.3.3. Fucosyltransferases
  • 9.3.4. GalNAc Transferases
  • 9.3.5. Galactosyl Transferases
  • 9.3.6. Glucuronosyltransferases
  • 9.3.7. Glucosyltransferases
  • 9.3.8. Pentosyltransferases
  • 9.3.9. Carbohydrate Kinases
  • 9.3.10. Neuraminidases
  • 9.3.11. Sialyltransferases
  • 9.3.12. Others
• 9.4. Market Attractiveness Analysis By Enzyme

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
  • 10.3.1. Drug Discovery and Development
  • 10.3.2. Diagnostic Applications
    • 10.3.2.1. Oncology
    • 10.3.2.2. Immunology
    • 10.3.2.3. Others
  • 10.3.3. Industrial Applications
  • 10.3.4. Therapeutic Applications
    • 10.3.4.1. Oncology
    • 10.3.4.2. Immunology
    • 10.3.4.3. Others
  • 10.3.5. Others
• 10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 11.3.1. Biopharmaceutical Companies
  • 11.3.2. Research Laboratories
  • 11.3.3. Hospitals
  • 11.3.4. Diagnostic Centres
  • 11.3.5. Contract Research Organizations
  • 11.3.6. Biotechnology Industries
  • 11.3.7. Academic Institutes
  • 11.3.8. Others
• 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. South Asia
  • 12.3.5. East Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product
  • 13.3.3. By Enzyme
  • 13.3.4. By Application
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Enzyme
  • 13.4.4. By Application
  • 13.4.5. By End User
• 13.5. Country Level Analysis & Forecast
  • 13.5.1. U.S. Market Analysis
    • 13.5.1.1. Introduction
    • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.1.2.1. By Product
      • 13.5.1.2.2. By Enzyme
      • 13.5.1.2.3. By Application
      • 13.5.1.2.4. By End User
  • 13.5.2. Canada Market Analysis
    • 13.5.2.1. Introduction
    • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.2.2.1. By Product
      • 13.5.2.2.2. By Enzyme
      • 13.5.2.2.3. By Application
      • 13.5.2.2.4. By End User
• 13.6. Market Trends
• 13.7. Key Market Participants - Intensity Mapping
• 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Brazil
    • 14.3.1.2. Mexico
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Enzyme
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Enzyme
  • 14.4.4. By Application
  • 14.4.5. By End User
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. Brazil Market Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Product
      • 14.5.1.2.2. By Enzyme
      • 14.5.1.2.3. By Application
      • 14.5.1.2.4. By End User
  • 14.5.2. Mexico Market Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Product
      • 14.5.2.2.2. By Enzyme
      • 14.5.2.2.3. By Application
      • 14.5.2.2.4. By End User
  • 14.5.3. Argentina Market Analysis
    • 14.5.3.1. Introduction
    • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.3.2.1. By Product
      • 14.5.3.2.2. By Enzyme
      • 14.5.3.2.3. By Application
      • 14.5.3.2.4. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. France
    • 15.3.1.3. Italy
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. Russia
    • 15.3.1.7. BENELUX
    • 15.3.1.8. Nordic Countries
    • 15.3.1.9. Rest of Europe
  • 15.3.2. By Product
  • 15.3.3. By Enzyme
  • 15.3.4. By Application
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Enzyme
  • 15.4.4. By Application
  • 15.4.5. By End User
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. Germany Market Analysis
    • 15.5.1.1. Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Product
      • 15.5.1.2.2. By Enzyme
      • 15.5.1.2.3. By Application
      • 15.5.1.2.4. By End User
  • 15.5.2. France Market Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Product
      • 15.5.2.2.2. By Enzyme
      • 15.5.2.2.3. By Application
      • 15.5.2.2.4. By End User
  • 15.5.3. Italy Market Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Product
      • 15.5.3.2.2. By Enzyme
      • 15.5.3.2.3. By Application
      • 15.5.3.2.4. By End User
  • 15.5.4. U.K. Market Analysis
    • 15.5.4.1. Introduction
    • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.4.2.1. By Product
      • 15.5.4.2.2. By Enzyme
      • 15.5.4.2.3. By Application
      • 15.5.4.2.4. By End User
  • 15.5.5. Spain Market Analysis
    • 15.5.5.1. Introduction
    • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.5.2.1. By Product
      • 15.5.5.2.2. By Enzyme
      • 15.5.5.2.3. By Application
      • 15.5.5.2.4. By End User
  • 15.5.6. Russia Market Analysis
    • 15.5.6.1. Introduction
    • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.6.2.1. By Product
      • 15.5.6.2.2. By Enzyme
      • 15.5.6.2.3. By Application
      • 15.5.6.2.4. By End User
  • 15.5.7. Nordic Countries Market Analysis
    • 15.5.7.1. Introduction
    • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.7.2.1. By Product
      • 15.5.7.2.2. By Enzyme
      • 15.5.7.2.3. By Application
      • 15.5.7.2.4. By End User
  • 15.5.8. BENELUX Market Analysis
    • 15.5.8.1. Introduction
    • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.8.2.1. By Product
      • 15.5.8.2.2. By Enzyme
      • 15.5.8.2.3. By Application
      • 15.5.8.2.4. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Thailand
    • 16.3.1.3. Indonesia
    • 16.3.1.4. Malaysia
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By Enzyme
  • 16.3.4. By Application
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Enzyme
  • 16.4.4. By Application
  • 16.4.5. By End User
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. India Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Product
      • 16.5.1.2.2. By Enzyme
      • 16.5.1.2.3. By Application
      • 16.5.1.2.4. By End User
  • 16.5.2. Thailand Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Product
      • 16.5.2.2.2. By Enzyme
      • 16.5.2.2.3. By Application
      • 16.5.2.2.4. By End User
  • 16.5.3. Indonesia Market Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Product
      • 16.5.3.2.2. By Enzyme
      • 16.5.3.2.3. By Application
      • 16.5.3.2.4. By End User
  • 16.5.4. Malaysia Market Analysis
    • 16.5.4.1. Introduction
    • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.4.2.1. By Product
      • 16.5.4.2.2. By Enzyme
      • 16.5.4.2.3. By Application
      • 16.5.4.2.4. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Enzyme
  • 17.3.4. By Application
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Enzyme
  • 17.4.4. By Application
  • 17.4.5. By End User
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. China Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Product
      • 17.5.1.2.2. By Enzyme
      • 17.5.1.2.3. By Application
      • 17.5.1.2.4. By End User
  • 17.5.2. Japan Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Product
      • 17.5.2.2.2. By Enzyme
      • 17.5.2.2.3. By Application
      • 17.5.2.2.4. By End User
  • 17.5.3. South Korea Market Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Product
      • 17.5.3.2.2. By Enzyme
      • 17.5.3.2.3. By Application
      • 17.5.3.2.4. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product
  • 18.3.3. By Enzyme
  • 18.3.4. By Application
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Enzyme
  • 18.4.4. By Application
  • 18.4.5. By End User
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. Australia Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Product
      • 18.5.1.2.2. By Enzyme
      • 18.5.1.2.3. By Application
      • 18.5.1.2.4. By End User
  • 18.5.2. New Zealand Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Product
      • 18.5.2.2.2. By Enzyme
      • 18.5.2.2.3. By Application
      • 18.5.2.2.4. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkiye
    • 19.3.1.3. Northern Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Product
  • 19.3.3. By Enzyme
  • 19.3.4. By Application
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Enzyme
  • 19.4.4. By Application
  • 19.4.5. By End User
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. GCC Countries Market Analysis
    • 19.5.1.1. Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Product
      • 19.5.1.2.2. By Enzyme
      • 19.5.1.2.3. By Application
      • 19.5.1.2.4. By End User
  • 19.5.2. Turkiye Market Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Product
      • 19.5.2.2.2. By Enzyme
      • 19.5.2.2.3. By Application
      • 19.5.2.2.4. By End User
  • 19.5.3. Northern Africa Market Analysis
    • 19.5.3.1. Introduction
    • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.3.2.1. By Product
      • 19.5.3.2.2. By Enzyme
      • 19.5.3.2.3. By Application
      • 19.5.3.2.4. By End User
  • 19.5.4. South Africa Market Analysis
    • 19.5.4.1. Introduction
    • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.4.2.1. By Product
      • 19.5.4.2.2. By Enzyme
      • 19.5.4.2.3. By Application
      • 19.5.4.2.4. By End User
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Branding and Promotional Strategies
• 21.3. Key Development Analysis
• 21.4. Competition Deep Dive
  • 21.4.1. Glycodiag
    • 21.4.1.1. Overview
    • 21.4.1.2. Product Portfolio
    • 21.4.1.3. Key Financials
    • 21.4.1.4. Sales Footprint
    • 21.4.1.5. SWOT Analysis
    • 21.4.1.6. Strategy Overview
  • 21.4.2. Tracxn Technologies Limited
    • 21.4.2.1. Overview
    • 21.4.2.2. Product Portfolio
    • 21.4.2.3. Key Financials
    • 21.4.2.4. Sales Footprint
    • 21.4.2.5. SWOT Analysis
    • 21.4.2.6. Strategy Overview
  • 21.4.3. Agilent Tecnologies, Inc.
    • 21.4.3.1. Overview
    • 21.4.3.2. Product Portfolio
    • 21.4.3.3. Key Financials
    • 21.4.3.4. Sales Footprint
    • 21.4.3.5. SWOT Analysis
    • 21.4.3.6. Strategy Overview
  • 21.4.4. Takara Bio Inc.
    • 21.4.4.1. Overview
    • 21.4.4.2. Product Portfolio
    • 21.4.4.3. Key Financials
    • 21.4.4.4. Sales Footprint
    • 21.4.4.5. SWOT Analysis
    • 21.4.4.6. Strategy Overview
  • 21.4.5. Bio-Techne
    • 21.4.5.1. Overview
    • 21.4.5.2. Product Portfolio
    • 21.4.5.3. Key Financials
    • 21.4.5.4. Sales Footprint
    • 21.4.5.5. SWOT Analysis
    • 21.4.5.6. Strategy Overview
  • 21.4.6. Bruker Corporation
    • 21.4.6.1. Overview
    • 21.4.6.2. Product Portfolio
    • 21.4.6.3. Key Financials
    • 21.4.6.4. Sales Footprint
    • 21.4.6.5. SWOT Analysis
    • 21.4.6.6. Strategy Overview
  • 21.4.7. Thermo Fisher Scientific Inc.
    • 21.4.7.1. Overview
    • 21.4.7.2. Product Portfolio
    • 21.4.7.3. Key Financials
    • 21.4.7.4. Sales Footprint
    • 21.4.7.5. SWOT Analysis
    • 21.4.7.6. Strategy Overview
  • 21.4.8. Shimadzu Corporation
    • 21.4.8.1. Overview
    • 21.4.8.2. Product Portfolio
    • 21.4.8.3. Key Financials
    • 21.4.8.4. Sales Footprint
    • 21.4.8.5. SWOT Analysis
    • 21.4.8.6. Strategy Overview
  • 21.4.9. New England Biolabs.
    • 21.4.9.1. Overview
    • 21.4.9.2. Product Portfolio
    • 21.4.9.3. Key Financials
    • 21.4.9.4. Sales Footprint
    • 21.4.9.5. SWOT Analysis
    • 21.4.9.6. Strategy Overview
  • 21.4.10. Waters.co.
    • 21.4.10.1. Overview
    • 21.4.10.2. Product Portfolio
    • 21.4.10.3. Key Financials
    • 21.4.10.4. Sales Footprint
    • 21.4.10.5. SWOT Analysis
    • 21.4.10.6. Strategy Overview
  • 21.4.11. Merck KGaA
    • 21.4.11.1. Overview
    • 21.4.11.2. Product Portfolio
    • 21.4.11.3. Key Financials
    • 21.4.11.4. Sales Footprint
    • 21.4.11.5. SWOT Analysis
    • 21.4.11.6. Strategy Overview
  • 21.4.12. Palleon Pharmaceuticals
    • 21.4.12.1. Overview
    • 21.4.12.2. Product Portfolio
    • 21.4.12.3. Key Financials
    • 21.4.12.4. Sales Footprint
    • 21.4.12.5. SWOT Analysis
    • 21.4.12.6. Strategy Overview
  • 21.4.13. Asparia Glycomics
    • 21.4.13.1. Overview
    • 21.4.13.2. Product Portfolio
    • 21.4.13.3. Key Financials
    • 21.4.13.4. Sales Footprint
    • 21.4.13.5. SWOT Analysis
    • 21.4.13.6. Strategy Overview
  • 21.4.14. RayBiotech Life,Inc.
    • 21.4.14.1. Overview
    • 21.4.14.2. Product Portfolio
    • 21.4.14.3. Key Financials
    • 21.4.14.4. Sales Footprint
    • 21.4.14.5. SWOT Analysis
    • 21.4.14.6. Strategy Overview
  • 21.4.15. Z Biotech,LLC.
    • 21.4.15.1. Overview
    • 21.4.15.2. Product Portfolio
    • 21.4.15.3. Key Financials
    • 21.4.15.4. Sales Footprint
    • 21.4.15.5. SWOT Analysis
    • 21.4.15.6. Strategy Overview
  • 21.4.16. Chemily Glycoscience
    • 21.4.16.1. Overview
    • 21.4.16.2. Product Portfolio
    • 21.4.16.3. Key Financials
    • 21.4.16.4. Sales Footprint
    • 21.4.16.5. SWOT Analysis
    • 21.4.16.6. Strategy Overview
  • 21.4.17. Lectenz Bio
    • 21.4.17.1. Overview
    • 21.4.17.2. Product Portfolio
    • 21.4.17.3. Key Financials
    • 21.4.17.4. Sales Footprint
    • 21.4.17.5. SWOT Analysis
    • 21.4.17.6. Strategy Overview
  • 21.4.18. 2BScientific
    • 21.4.18.1. Overview
    • 21.4.18.2. Product Portfolio
    • 21.4.18.3. Key Financials
    • 21.4.18.4. Sales Footprint
    • 21.4.18.5. SWOT Analysis
    • 21.4.18.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료